BioAtla, Inc. (BCAB)
1.71
+0.48
(+39.02%)
USD |
OTCM |
Oct 23, 16:00
BioAtla Market Cap : 2.844M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.844M |
| October 22, 2026 | 2.046M |
| October 21, 2026 | 2.255M |
| October 20, 2026 | 2.212M |
| October 19, 2026 | 2.179M |
| October 16, 2026 | 2.262M |
| October 15, 2026 | 2.162M |
| October 14, 2026 | 2.162M |
| October 13, 2026 | 2.129M |
| October 12, 2026 | 2.079M |
| October 09, 2026 | 2.495M |
| October 08, 2026 | 2.578M |
| October 07, 2026 | 2.645M |
| October 06, 2026 | 2.246M |
| October 05, 2026 | 2.196M |
| October 02, 2026 | 2.179M |
| October 01, 2026 | 2.096M |
| September 30, 2026 | 2.162M |
| September 29, 2026 | 2.262M |
| September 28, 2026 | 2.528M |
| September 25, 2026 | 2.462M |
| September 24, 2026 | 2.528M |
| September 23, 2026 | 2.645M |
| September 22, 2026 | 2.944M |
| September 21, 2026 | 3.194M |
| Date | Value |
|---|---|
| September 18, 2026 | 2.977M |
| September 17, 2026 | 3.160M |
| September 16, 2026 | 3.992M |
| September 15, 2026 | 2.279M |
| September 14, 2026 | 2.445M |
| September 11, 2026 | 2.495M |
| September 10, 2026 | 1.963M |
| September 09, 2026 | 2.046M |
| September 08, 2026 | 2.096M |
| September 04, 2026 | 2.196M |
| September 03, 2026 | 2.162M |
| September 02, 2026 | 2.004M |
| September 01, 2026 | 1.796M |
| August 31, 2026 | 2.811M |
| August 28, 2026 | 2.886M |
| August 27, 2026 | 5.223M |
| August 26, 2026 | 5.190M |
| August 25, 2026 | 5.422M |
| August 24, 2026 | 5.456M |
| August 21, 2026 | 5.289M |
| August 20, 2026 | 5.289M |
| August 19, 2026 | 5.439M |
| August 18, 2026 | 5.289M |
| August 17, 2026 | 5.090M |
| August 14, 2026 | 5.140M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.873B |
| Anixa Biosciences, Inc. | 103.41M |
Market Cap Related Metrics
| PS Ratio | 0.2783 |
| Price | 1.71 |
| Earnings Yield | -1.49K% |